Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0160
+0.0010 (6.67%)
Mar 4, 2026, 4:10 PM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 25.62 million as of March 4, 2026. Its market cap has increased by 116.89% in one year.
Market Cap
25.62M
Enterprise Value
23.73M
Revenue
-26.16K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 25.62M, an increase of 110.53%. That is a compound annual growth rate of 3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 25.62M | 8.36% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 63.35M |
| Amplia Therapeutics | 61.57M |
| Proteomics International Laboratories | 56.16M |
| Entropy Neurodynamics | 54.87M |
| NeuroScientific Biopharmaceuticals | 34.92M |
| Avecho Biotechnology | 33.06M |
| Argenica Therapeutics | 28.90M |
| Patrys | 20.88M |